GeneDx stock drops again: WGS slides on 2026 outlook as JPM talk nears
Shares of GeneDx Holdings Corp dropped roughly 8.7% to $108.90 Tuesday afternoon, continuing their slide after the genetic testing firm revealed its 2026 revenue forecast the previous day.